AV-380

Novartis dumps worldwide rights to an Aveo drug, and the little biotech is not happy with them
Endpoints
Tue, 07/3/18 - 11:18 am
Novartis
Aveo
GDF15
AV-380
Novartis bets on a slumping Aveo in a $326M cancer deal
Fierce Biotech
Mon, 08/17/15 - 10:13 am
Novaris
Aveo Oncology
AV-380